经导管瓣膜病介入治疗的中国数据
Transcatheter valve interventions: data from China
11/04 16:20-18:20
会场2 (Room 2)
-
纽脉医疗提供学术支持
-
16:20-18:20
-
16:20-18:20
-
16:20-16:30PrizValve TAVI研究的1年临床结果One-year outcomes of the PrizValve TAVI Pivotal Study
-
16:30-16:35讨论Discussion
-
16:35-16:45DragonFly Mitral TEER 研究的1年临床结果One-year outcomes of the DragonFly Mitral TEER Pivotal study
-
16:45-16:50讨论Discussion
-
16:50-17:00
-
17:00-17:05讨论Discussion
-
17:05-17:15GeminiOne Mitral TEER研究进展Update of the GeminiOne Mitral TEER study
-
17:15-17:20讨论Discussion
-
17:20-17:30
-
17:30-17:35讨论Discussion
-
17:35-17:45全球首款多聚物TAVI系统TRISKELE的FIM结果First-in-man experience of TAVI with the polymer TRISKELE system
-
17:45-17:50讨论Discussion
-
17:50-18:00牛心包TaurusOne瓣膜用于TAVI治疗的4年临床结果Four-year outcomes after TAVI with a bovine percardial valve
-
18:00-18:05讨论Discussion
-
18:05-18:15VitaFlow瓣膜用于TAVI治疗的7年临床结果Six-year outcomes after TAVI with the VitaFlow valve
-
18:15-18:20讨论Discussion